KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $144.0 million.

  • Quest Diagnostics' Capital Expenditures rose 3584.91% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $492.0 million, marking a year-over-year increase of 3155.08%. This contributed to the annual value of $425.0 million for FY2024, which is 416.67% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Capital Expenditures is $144.0 million, which was up 3584.91% from $108.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Capital Expenditures high stood at $147.0 million for Q4 2022, and its period low was $63.0 million during Q1 2022.
  • For the 5-year period, Quest Diagnostics' Capital Expenditures averaged around $105.7 million, with its median value being $105.0 million (2023).
  • Within the past 5 years, the most significant YoY rise in Quest Diagnostics' Capital Expenditures was 10158.73% (2023), while the steepest drop was 5102.04% (2023).
  • Over the past 5 years, Quest Diagnostics' Capital Expenditures (Quarter) stood at $144.0 million in 2021, then rose by 2.08% to $147.0 million in 2022, then plummeted by 51.02% to $72.0 million in 2023, then surged by 70.83% to $123.0 million in 2024, then rose by 17.07% to $144.0 million in 2025.
  • Its Capital Expenditures was $144.0 million in Q3 2025, compared to $108.0 million in Q2 2025 and $117.0 million in Q1 2025.